secwatch / observer
8-K filed November 1, 2022, 7:59 PM ET ticker CLX CIK 0000021076
earnings confidence high sentiment negative materiality 0.70

Clorox Q1 sales down 4% to $1.74B; EPS falls 40%; confirms FY outlook

CLOROX CO /DE/

2023-Q1 EPS reported $0.68 revenue$1,740,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLOROX CO /DE/ reported first quarter of fiscal year 2023, which ended Sept. 30, 2022 results: revenue $1.74 billion, EPS 68 cents. Guidance reaffirmed.

Period
first quarter of fiscal year 2023, which ended Sept. 30, 2022
Revenue
$1.74 billion
EPS
68 cents
Guidance
reaffirmed
Result
reported results
Exact text from the filing
The Clorox Company (NYSE: CLX) today reported results for the first quarter of fiscal year 2023, which ended Sept. 30, 2022. First-Quarter Fiscal Year 2023 Summary Following is a summary of key first-quarter results. All comparisons are with the first quarter of fiscal year 2022 unless otherwise stated. • Net sales decreased 4% to $1.74 billion compared to a 6% net sales decrease in the year-ago quarter. The net sales decrease was driven largely by lower volume, partially offset by favorable price mix. Organic sales 1 were down 2%. The three-year average growth rate for net sales was up 5%. • Gross margin decreased 110 basis points to 36% from 37.1% in the year-ago quarter, due to higher manufacturing and logistics costs, higher commodity costs, and lower volume, partially offset by the benefits of pricing and cost savings initiatives. • Diluted net earnings per share (diluted EPS) decreased 40% to 68 cents from $1.14 in the year-ago quarter.
View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR
accession 0000021076-22-000033
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.